I am a little surprised by the reaction after the complete opposite reaction to last weeks smaller insider offer and the fact that this could be the end of the Paulson rounds if it works out. In my mind it is crazy that the science doesn't move us much (so far) and it was always lack of financing to get to revenue and now that this is possibly in the works (even if not great terms) it could cure those issues, yet the stock still gets slammed. It is difficult to watch and I am at my risk level, but I still bought more today knowing that I am investing longer term and nothing has changed in that aspect (other than for the better).
I see that ASCM is on the bid/ask today and recall Trding mentioning that they are a known short MM.....hopefully some of the recent action is some convertible notes also but seems those have been towards the end of the month previously.
Either way, the bleeding has to stop somewhere and I can't see them not making it to the finish line. I guess we will just have to wait and see what the cost is to get there, but I'm not selling until I find out.
I don't have any new guesses, but my hope is not more Paulson rounds. That would be horrible as I'm sure the terms and price would be ugly.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.